Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models

Molecular Oncology

Volumn 7, Issue 3, 2013, Pages 543-554

  Yi, Bo Rim ^a   Park, Min Ah ^a   Lee, Hye Rim ^a   Kang, Nam Hee ^a   Choi, Kelvin J ^b   Kim, Seung U ^b,c   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

Colorectal cancer; Cytosine deaminase; Interferon beta; Therapeutic stem cells; Xenograft model

Indexed keywords

BETA INTERFERON; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER MODEL; CANCER SURVIVAL; CELL MIGRATION; COCULTURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ESCHERICHIA COLI; GENETICALLY ENGINEERED STEM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; SUICIDE GENE THERAPY;

ESCHERICHIA COLI; MUS;

EID: 84878106200     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.01.004     Document Type: Article

References (50)

1. Aboody K.S., Bush R.A., Garcia E., Metz M.Z., Najbauer J., Justus K.A., Phelps D.A., Remack J.S., Yoon K.J., Gillespie S., Kim S.U., Glackin C.A., Potter P.M., Danks M.K. Development of a tumor-selective approach to treat metastatic cancer. PLoS One 2006, 1:e23.
2. Aboody K.S., Najbauer J., Danks M.K. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 2008, 15:739-752.
3. Altaner C. Prodrug cancer gene therapy. Cancer Lett. 2008, 270:191-201.
4. Bird N.C., Mangnall D., Majeed A.W. Biology of colorectal liver metastases: a review. J. Surg. Oncol. 2006, 94:68-80.
5. Boucher P.D., Im M.M., Freytag S.O., Shewach D.S. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. Cancer Res. 2006, 66:3230-3237.
6. Brown A.B., Yang W., Schmidt N.O., Carroll R., Leishear K.K., Rainov N.G., Black P.M., Breakefield X.O., Aboody K.S. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 2003, 14:1777-1785.
7. Chung-Faye G.A., Chen M.J., Green N.K., Burton A., Anderson D., Mautner V., Searle P.F., Kerr D.J. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase. Gene Ther. 2001, 8:1547-1554.
8. Conrad C., Gupta R., Mohan H., Niess H., Bruns C.J., Kopp R., von Luettichau I., Guba M., Heeschen C., Jauch K.W., Huss R., Nelson P.J. Genetically engineered stem cells for therapeutic gene delivery. Curr. Gene Ther. 2007, 7:249-260.
9. Crystal R.G., Hirschowitz E., Lieberman M., Daly J., Kazam E., Henschke C., Yankelevitz D., Kemeny N., Silverstein R., Ohwada A., Russi T., Mastrangeli A., Sanders A., Cooke J., Harvey B.G. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine. Hum. Gene Ther. 1997, 8:985-1001.
10. Dietrich J., Imitola J., Kesari S. Mechanisms of disease: the role of stem cells in the biology and treatment of gliomas. Nat. Clin. Pract. Oncol. 2008, 5:393-404.
11. Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., Jandik P., Iveson T., Carmichael J., Alakl M., Gruia G., Awad L., Rougier P. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355:1041-1047.
12. Ehtesham M., Yuan X., Kabos P., Chung N.H., Liu G., Akasaki Y., Black K.L., Yu J.S. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004, 6:287-293.
13. Fodde R. Stem cells and metastatic cancer: fatal attraction?. PLoS Med. 2006, 3:e482.
14. Freytag S.O., Khil M., Stricker H., Peabody J., Menon M., DePeralta-Venturina M., Nafziger D., Pegg J., Paielli D., Brown S., Barton K., Lu M., Aguilar-Cordova E., Kim J.H. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 2002, 62:4968-4976.
15. Hartmann K.U., Heidelberger C. Studies on fluorinated pyrimidines. XIII. Inhibition of thymidylate synthetase. J. Biol. Chem. 1961, 236:3006-3013.
16. Hirschowitz E.A., Ohwada A., Pascal W.R., Russi T.J., Crystal R.G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 1995, 6:1055-1063.
17. Huber B.E., Austin E.A., Richards C.A., Davis S.T., Good S.S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:8302-8306.
18. Juang S.H., Wei S.J., Hung Y.M., Hsu C.Y., Yang D.M., Liu K.J., Chen W.S., Yang W.K. IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines. J. Interferon. Cytokine Res. 2004, 24:231-243.
19. Kaliberov S.A., Market J.M., Gillespie G.Y., Krendelchtchikova V., Della Manna D., Sellers J.C., Kaliberova L.N., Black M.E., Buchsbaum D.J. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther. 2007, 14:1111-1119.
20. Kanai F., Lan K.H., Shiratori Y., Tanaka T., Ohashi M., Okudaira T., Yoshida Y., Wakimoto H., Hamada H., Nakabayashi H., Tamaoki T., Omata M. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res. 1997, 57:461-465.
21. Kashiwagi K., Furusyo N., Kubo N., Nakashima H., Nomura H., Kashiwagi S., Hayashi J. A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development. J. Infect. Chemother. 2003, 9:333-340.
22. Kim K.Y., Kim S.U., Leung P.C., Jeung E.B., Choi K.C. Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. Cancer Sci. 2010, 101:955-962.
23. Kim K.Y., Yi B.R., Lee H.R., Kang N.H., Jeung E.B., Kim S.U., Choi K.C. Stem cells with fused gene expression of cytosine deaminase and interferon-beta migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use. Int. J. Oncol. 2012, 40:1097-1104.
24. Kim S.K., Kim S.U., Park I.H., Bang J.H., Aboody K.S., Wang K.C., Cho B.K., Kim M., Menon L.G., Black P.M., Carroll R.S. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res. 2006, 12:5550-5556.
25. Kim S.U. Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev. 2011, 7:130-140.
26. Kim S.U. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004, 24:159-171.
27. Kim S.U. Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Dev. 2007, 29:193-201.
28. Kim S.U., Jeung E.B., Kim Y.B., Cho M.H., Choi K.C. Potential tumor-tropic effect of genetically engineered stem cells expressing suicide enzymes to selectively target invasive cancer in animal models. Anticancer Res. 2011, 31:1249-1258.
29. Kim S.U., Nakagawa E., Hatori K., Nagai A., Lee M.A., Bang J.H. Production of immortalized human neural crest stem cells. Methods Mol. Biol. 2002, 198:55-65.
30. Kohase M., Henriksen-DeStefano D., May L.T., Vilcek J., Sehgal P.B. Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986, 45:659-666.
31. Kucerova L., Altanerova V., Matuskova M., Tyciakova S., Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007, 67:6304-6313.
32. Milsom J.W., Bohm B., Hammerhofer K.A., Fazio V., Steiger E., Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J. Am. Coll. Surg. 1998, 187:46-54. discussion 54-45.
33. Mullen C.A., Kilstrup M., Blaese R.M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:33-37.
34. Muller F.J., Snyder E.Y., Loring J.F. Gene therapy: can neural stem cells deliver?. Nat. Rev. 2006, 7:75-84.
35. Nagano H., Miyamoto A., Wada H., Ota H., Marubashi S., Takeda Y., Dono K., Umeshita K., Sakon M., Monden M. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules. Cancer 2007, 110:2493-2501.
36. Nakamizo A., Marini F., Amano T., Khan A., Studeny M., Gumin J., Chen J., Hentschel S., Vecil G., Dembinski J., Andreeff M., Lang F.F. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005, 65:3307-3318.
37. Nakamura K., Ito Y., Kawano Y., Kurozumi K., Kobune M., Tsuda H., Bizen A., Honmou O., Niitsu Y., Hamada H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004, 11:1155-1164.
38. Pessino A., Sobrero A. Optimal treatment of metastatic colorectal cancer. Expert Rev. Anticancer Ther. 2006, 6:801-812.
39. Reiser J., Zhang X.Y., Hemenway C.S., Mondal D., Pradhan L., La Russa V.F. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin. Biol. Ther. 2005, 5:1571-1584.
40. Ren C., Kumar S., Chanda D., Kallman L., Chen J., Mountz J.D., Ponnazhagan S. Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther. 2008, 15:1446-1453.
41. Saukkonen K., Hemminki A. Tissue-specific promoters for cancer gene therapy. Expert Opin. Biol. Ther. 2004, 4:683-696.
42. Schmidt N.O., Przylecki W., Yang W., Ziu M., Teng Y., Kim S.U., Black P.M., Aboody K.S., Carroll R.S. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005, 7:623-629.
43. Studeny M., Marini F.C., Dembinski J.L., Zompetta C., Cabreira-Hansen M., Bekele B.N., Champlin R.E., Andreeff M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 2004, 96:1593-1603.
44. Sun L., Hui A.M., Su Q., Vortmeyer A., Kotliarov Y., Pastorino S., Passaniti A., Menon J., Walling J., Bailey R., Rosenblum M., Mikkelsen T., Fine H.A. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006, 9:287-300.
45. Sun L., Lee J., Fine H.A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest. 2004, 113:1364-1374.
46. Yazawa K., Fisher W.E., Brunicardi F.C. Current progress in suicide gene therapy for cancer. World J. Surg. 2002, 26:783-789.
47. Yi B.R., Kang N.H., Hwang K.A., Kim S.U., Jeung E.B., Choi K.C. Antitumor therapeutic effects of cytosine deaminase and interferon-beta against endometrial cancer cells using genetically engineered stem cells in vitro. Anticancer Res. 2011, 31:2853-2861.
48. Yi B.R., O S.N., Kang N.H., Hwang K.A., Kim S.U., Jeung E.B., Kim Y.B., Heo G.J., Choi K.C. Genetically engineered stem cells expressing cytosine deaminase and interferon-beta migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Int. J. Oncol. 2011, 39:833-839.
49. You M.H., Kim W.J., Shim W., Lee S.R., Lee G., Choi S., Kim D.Y., Kim Y.M., Kim H., Han S.U. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model. J. Gastroenterol. Hepatol. 2009, 24:1393-1400.
50. Zhao D., Najbauer J., Garcia E., Metz M.Z., Gutova M., Glackin C.A., Kim S.U., Aboody K.S. Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol. Cancer Res. 2008, 6:1819-1829.